Established how LGALS9B controls EEF1D abundance: rather than acting catalytically, it physically competes with the E3 ligase HERC5 for EEF1D, answering whether the protein's effect is stabilizing and direct.
Evidence Co-immunoprecipitation/binding competition assay with knockdown/overexpression and protein stability readouts, in vitro and in vivo
- Single lab with limited orthogonal validation described
- Binding interface and stoichiometry of LGALS9B-EEF1D-HERC5 competition not defined
- Whether this mechanism operates outside gastric cancer cells is untested